Perseus Proteomics
5 known investors
Find your way into Perseus Proteomics
Perseus Proteomics develops and supplies research antibodies targeting nuclear receptors and transcription factors, along with ELISA kits and diagnostic assays, serving life sciences researchers and pharmaceutical development. The company provides approximately 100 antibody products including anti-ERβ antibodies established as the gold standard for ERβ research, as well as specialized antibodies for drug-antibody conjugates and radioimmunoterapy applications.
Investors · 5
In the news
Frequently asked questions
- What does Perseus Proteomics do?
- Perseus Proteomics develops and supplies research antibodies targeting nuclear receptors and transcription factors, along with ELISA kits and diagnostic assays, serving life sciences researchers and pharmaceutical development. The company provides approximately 100 antibody products including anti-ERβ antibodies established as the gold standard for ERβ research, as well as specialized antibodies for drug-antibody conjugates and radioimmunoterapy applications.
- Who are Perseus Proteomics's investors?
- Perseus Proteomics's investors include DBJ Capital, Kyoto University Innovation Capital, Newton Biocapital, Nippon Venture Capital, SMBC Venture Capital.